Infectious Disease Billing and Coding Services

There is no single set of CPT codes used for every infectious disease service. Coding may involve evaluation and management services, hospital consultations where applicable, infusion administration, drug administration, and other services supported by the documentation. The correct code depends on the setting, provider work, time or medical decision-making, and payer rules. Claims should be reviewed against current official coding guidance and payer requirements.

Support may include charge entry, coding review, claim scrubbing, submission, rejection clearing, denial analysis, appeals, payment reconciliation, authorization work, and accounts-receivable follow-up. For ID and infusion practices, review commonly considers office or hospital services alongside drug and administration claims. The appropriate scope depends on whether a practice needs full claims management, overflow assistance, consulting, or help with a specific revenue-cycle problem.

Infusion and drug claims require coordination among documentation, administration coding, units, drug identifiers, authorization, and the applicable medical or pharmacy benefit. A billing review should compare the clinical record and charge capture with the submitted claim and payer response. Payment reconciliation can then identify mismatches, short-pays, incorrect fee schedule application, or other issues affecting reimbursement.

Common causes include missing or incomplete authorization, confusion between medical and pharmacy benefits, unsupported documentation, drug or administration coding issues, and claim details that do not match payer requirements. Denial management is more effective when denials are categorized by root cause and the appeal addresses the specific payer issue with relevant clinical and billing documentation. Findings should also be shared with teams to reduce repeat denials.

Yes. OPAT workflows may require eligibility and benefit verification, identification of the responsible benefit, prior authorization, drug and administration billing review, and coordination across clinical and administrative teams. A structured process can help practices track each request, connect authorization information to the claim, and identify where unreimbursed drug costs or delayed approvals may arise.

Revenue leakage may occur through under-leveled visits, missed drug or administration charges, incomplete documentation, unpursued balances, contract issues, or payment discrepancies. Reporting by payer, service line, and provider can reveal denial patterns, payment trends, and accounts-receivable health. Tracing findings back to documentation, charge capture, contracts, or workflow helps the practice address the source rather than only correcting individual claims.

Revenue-cycle consulting can review the workflow from referral through final payment, including documentation, coding, eligibility, authorization, drug acquisition, infusion billing, denials, underpayments, accounts-receivable follow-up, and payer or hospital coverage agreements. The outcome is a prioritized, practical view of where revenue is lost, delayed, or left uncollected, with recommendations aligned to the practice’s services and operating model.

Yes. The resources are intended for infectious disease physicians, independent infectious disease practices, infectious disease group leaders, and medical practice administrators. Guidance can help teams evaluate revenue streams, infusion or OPAT decisions, payer workflows, staffing considerations, and collection problems. Practices can use their own operating and financial information rather than relying on generalized rates, margins, or unsupported assumptions.